More than 700 medical experts, pharmaceutical executives, patient advocates, and others are expected to converge on Washington, D.C., next month for the 2018 NORD Rare Diseases Orphan Products Breakthrough Summit.
The Oct. 15-16 event, sponsored by the National Organization for Rare Diseases (NORD), takes place at the Marriott Wardman Park Hotel. BioNews Services, which publishes this website, will cover the conference onsite.
“Registration for the summit has been very busy,” Mary Dunkle, NORD’s vice-president of educational initiatives, said in an email. “This is the only conference where you can interact directly with thought leaders from over 100 patient advocacy organizations, government, medical professionals, and the orphan product industry — in an environment of real collaboration and insight.”
Scott Gottlieb, MD, commissioner of the U.S. Food and Drug Administration (FDA), will deliver the keynote speech on “A New Era of Patient-focused Innovation,” which is the theme of this